Suxin Li
Impact in
- Immunology top 5%
- interferon and immune responses
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 16
- interferon and immune responses 9
- Immune cells in cancer 5
- Immune Response and Inflammation 4
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Jinming Gao (9 shared papers)Baran D. Sumer (7 shared papers)Jian Wang (7 shared papers)Jonathan Wilhelm (6 shared papers)Xueqing Wang (8 shared papers)Wenbing Dai (7 shared papers)Bing He (7 shared papers)Binlong Chen (4 shared papers)
- Journals
- Journal of Controlled Release (4 papers)ACS Nano (3 papers)Nature Communications (2 papers)Nature Biomedical Engineering (2 papers)International Journal of Nanomedicine (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Suxin Li
39 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 534
- Biomaterials 284
- Cancer Research 170
- Biomedical Engineering 435
- Molecular Biology 619
Countries citing papers authored by Suxin Li
This map shows the geographic impact of Suxin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxin Li more than expected).
Fields of papers citing papers by Suxin Li
This network shows the impact of papers produced by Suxin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxin Li. The network helps show where Suxin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Suxin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity Hit paper breakdown → | 2022 | 254 |
| 2 | Prolonged activation of innate immune pathways by a polyvalent STING agonist Hit paper breakdown → | 2021 | 240 |
| 3 | 2016 | 138 | |
| 4 | 2016 | 127 | |
| 5 | 2014 | 87 | |
| 6 | 2020 | 79 | |
| 7 | 2016 | 71 | |
| 8 | 2017 | 68 | |
| 9 | STING licensing of type I dendritic cells potentiates antitumor immunity Hit paper breakdown → | 2024 | 63 |
| 10 | 2018 | 45 | |
| 11 | 2020 | 41 | |
| 12 | 2021 | 26 | |
| 13 | 2017 | 26 | |
| 14 | 2023 | 21 | |
| 15 | 2017 | 16 | |
| 16 | 2022 | 14 | |
| 17 | 2021 | 14 | |
| 18 | 2017 | 13 | |
| 19 | 2019 | 12 | |
| 20 | 2024 | 10 |
About Suxin Li
Suxin Li is a scholar working on Immunology, Molecular Biology, Biomedical Engineering, Biomaterials and Plant Science, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include interferon and immune responses (9 papers), Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Immune cells in cancer (5 papers), Plant Molecular Biology Research (4 papers), Immune Response and Inflammation (4 papers), RNA Interference and Gene Delivery (4 papers) and Viral Infections and Vectors (4 papers). The work is most often cited by research in Immunology (534 citations), Biomaterials (284 citations), Cancer Research (170 citations), Biomedical Engineering (435 citations) and Molecular Biology (619 citations). Suxin Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jinming Gao, Baran D. Sumer, Jian Wang, Jonathan Wilhelm, Xueqing Wang, Wenbing Dai, Bing He, Binlong Chen, Qiang Feng and Hua Zhang. Their work appears in journals such as Journal of Controlled Release, ACS Nano, Nature Communications, Nature Biomedical Engineering and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.